Protective effects of hesperidin against genotoxicity induced by 99mTc-MIBI in human cultured lymphocyte cells

Nuclear Medicine and Biology

Volumn 36, Issue 7, 2009, Pages 863-867

  Hosseinimehr, Seyed Jalal ^a   Ahmadi, Amirhossein ^a   Beiki, Davood ^b   Habibi, Emran ^a   Mahmoudzadeh, Aziz ^c  

^a School of Pharmacy and Traditional   (Iran)

^b TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c Novin Medical Radiation Institute   (Iran)

Author keywords

99mTc MIBI; Genotoxicity; Hesperidin; Micronucleus; Radiopharmaceutical

Indexed keywords

HESPERIDIN; METHOXY ISOBUTYL ISONITRILE TECHNETIUM TC 99M; RADIOPHARMACEUTICAL AGENT;

ADULT; ARTICLE; BLOOD SAMPLING; CONCENTRATION RESPONSE; CONTROLLED STUDY; CORONARY ARTERY BLOOD FLOW; GENETIC DAMAGE; GENOTOXICITY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMAGING; INCUBATION TIME; LYMPHOCYTE ACTIVATION; LYMPHOCYTE CULTURE; MALE; MICRONUCLEUS; NORMAL HUMAN; RADIATION PROTECTION;

ADULT; CELLS, CULTURED; DOSE-RESPONSE RELATIONSHIP, DRUG; HESPERIDIN; HUMANS; LYMPHOCYTES; MALE; MICRONUCLEUS TESTS; MUTAGENS; RADIATION-PROTECTIVE AGENTS; TECHNETIUM TC 99M SESTAMIBI;

EID: 69249214023     PISSN: 09698051     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.nucmedbio.2009.06.002     Document Type: Article

References (22)

1. Hosseinimehr S.J. Trends in the development of radioprotective agents. Drug Discov Today 12 (2007) 794-805
2. 99mTc. Radiat Prot Dosim 122 (2006) 80-81
3. Schwochau K. Technetium radiopharmaceuticals-fundamentals, synthesis, structure and development. Angew Chem Ed Engl 33 (1994) 2258-2267
4. Merz T., Tatum J., and Hirsch J. Technetium-99m-labeled lymphocytes: a radiotoxicity study. J Nucl Med 27 (1986) 105-110
5. 99mtechnetium-MIBI in human peripheral blood lymphocytes: ex vivo study using micronucleus/FISH assay. Cancer Let 233 (2006) 68-78
6. 99mTc-sestamibi at rest, during peak exercise and after dipyridamole infusion. Clin Physiol Funct Imaging 24 (2004) 394-397
7. Hosseinimehr S.J., and Nemati A. Radioprotective effects of hesperidin against gamma irradiation in mouse bone marrow cells. Br J Radiol 79 (2006) 415-418
8. Garg A., Garg S., Zaneveled J.D., and Singla A.K. Chemistry and pharmacology of the citrus bioflavonoid hesperidin. Phytotherapy Res 15 (2001) 655-669
9. Yang M., Tanaka T., Hirose Y., Deguchi T., Mori H., and Kawada Y. Chemopreventive effects of diosmin and hesperidin on N-butyl-N-(4-hydroxybutyl) nitrosamine-induced urinary-bladder carcinogenesis in male ICR mice. Int J Cancer 73 (1997) 719-724
10. Fenech M. The in vitro micronucleus technique. Mutat Res 455 (2000) 81-95
11. Lundqvist H., Antoni G., and Långström B. Genotoxic hazard of radiopharmaceuticals in humans: chemical and radiation aspects coupled to microdosing. Eur J Clin Pharmacol 63 (2007) 641-645
12. 99mTc-MIBI on chromosomal damage induction among patients undergoing myocardial perfusion scan. Pajoohandeh 9-15 (2008) 13 [Persian]
13. 99mTc: in vitro and in vivo studies. Nucl Med Commun 26 (2005) 913-918
14. Kelsey K.T., Donohoe K.J., Memisoglu A., Baxter B., Caggana M., and Liber H.L. In vivo exposure of human lymphocytes to technetium-99m in nuclear medicine patients does not induce detectable genetic effects. Mutat Res 264 (1991) 213-218
15. Tanaka T., Kohno H., Murakami M., Shimada R., Kagami S., Sumida T., et al. Suppression of azoxymethane-induced colon carcinogenesis in male F344 rats by mandarin juice in β-cryptoxanthin and hesperidin. Int J Cancer 88 (2000) 146-150
16. Tanaka T., Makita H., Kawabata K., et al. Chemoprevention of azoxymethane-induced rat colon carcinogenesis by naturally occurring flavonoids, diosmin and hesperidin. Carcinogenesis 18 (1997) 957-965
17. Tirkey N., Pilkhwal S., Kuhad A., and Chopra K. Hesperidin, a citrus bioflavonoid, decreases the oxidative stress produced by carbon tetrachloride in rat liver and kidney. BMC Pharmacol 5 (2005) 1-8
18. 2-induced cytotoxicity in PC12 cells. J Agri Food Chem 13 (2008) 859-864
19. Shimoi K., Masuda S., Furugori M., Esaki S., and Kinae N. Radioprotective effect on antioxidative flavonoids in γ-ray irradiated mice. Carcinogenesis 15 (1994) 2669-2672
20. 2+. Zhong Yao Cai 30 (2007) 677-681
21. Pradeep K., Park S.H., and Ko K.C. Hesperidin a flavanoglycone protects against γ-irradiation induced hepatocellular damage and oxidative stress in Sprague-Dawley rats. Eur J Pharmacol 587 (2008) 273-280
22. Nielsen I.L., Chee W.S.S., Poulsen L., Offord-Cavi E., Rasmussen S.E., and Frederiksen H. Bioavailability is improved by enzymatic modification of the citrus flavonoid hesperidin in humans: a randomized, double-blind, crossover trial. J Nutr 136 (2006) 404-408